Medicure (TSE:MPH) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Medicure Inc. reported a slight increase in total net revenue for Q3 2024, reaching $5.2 million compared to $5.0 million in the same quarter last year. Despite a drop in AGGRASTAT sales, the company experienced growth in revenue from its Marley Drug business, contributing to a notable rise in net income to $680,000 from the previous year’s $84,000.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue